Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity
A Pilot Study of Cardiopulmonary Exercise Testing in Patients With Left Ventricular Systolic Dysfunction Receiving HER2-Targeted Therapy
Sponsor: Memorial Sloan Kettering Cancer Center
Listed as NCT05036252, this observational or N/A phase trial focuses on Breast Cancer and Breast Cancer Stage I and remains ongoing. Sponsored by Memorial Sloan Kettering Cancer Center, it has been updated 8 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Oct 2025 — Present [monthly]
Active Not Recruiting
-
Jun 2025 — Oct 2025 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Oct 2024 — Jun 2025 [monthly]
Recruiting
-
Sep 2024 — Oct 2024 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
▶ Show 3 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Recruiting
-
Sep 2022 — Oct 2023 [monthly]
Recruiting
-
Oct 2021 — Sep 2022 [monthly]
Recruiting
First recorded
Aug 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Memorial Sloan Kettering Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .